Skip to main content
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc. — Investor Relations & Filings

Ticker · BCAX ISIN · US0554771032 US Manufacturing
Filings indexed 169 across all filing types
Latest filing 2025-08-12 Interim / Quarterly Rep…
Country US United States of America
Listing US BCAX

About Bicara Therapeutics Inc.

https://www.bicara.com/

Bicara Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing first-in-class, dual-action biologics for cancer treatment. The company engineers bifunctional therapies that combine the precision of targeted treatments with the activation of a potent and durable anti-tumor immune response. This approach is designed to deliver therapeutic impact directly within the tumor microenvironment, with a primary focus on developing treatments for patients with solid tumors.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2025
2025-08-12 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated August 12, 2025, reporting the issuance of a press release announcing financial results and business highlights for the quarter ended June 30, 2025. The text states that the press release is furnished as an exhibit and incorporated by reference, indicating this document is a current report announcing earnings results rather than the earnings release itself. The document length is 3636 characters, which is relatively short and consistent with a Form 8-K filing announcing earnings results. According to the definitions, an initial announcement of quarterly financial results is classified as an Earnings Release (ER). Since the document is a Form 8-K announcing quarterly results and includes a press release, the best fit is Earnings Release (ER).
2025-08-12 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-31 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-17 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-07-17 English
FORM 4
Director's Dealing
2025-06-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.